Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Adverse Events Associated With Meropenem Versus Imipenem/Cilastatin Therapy in a Large Retrospective Cohort of Hospitalized Infants

UNC Libraries(2020)10.17615/z3sw-kr95Source: DataRank Database

Adverse Events Associated With Meropenem Versus Imipenem/Cilastatin Therapy in a Large Retrospective Cohort of Hospitalized Infants is a research paper published in UNC Libraries (2020). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.00)OA: greenTopics (31)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Reese H. Clark ORCID,P. Brian Smith ORCID,Amy H. Herring ORCID,Michael Cohen‐Wolkowiez ORCID,Gregory L. Kearns

Live enrichment

PubMed:19965766 OpenAlex:https://openalex.org/W4300651616

European Commission

Grant: 261060

Global Research in Paediatrics

FWCI

0.00

Citation Percentile

0.3%

greenLicense: http://rightsstatements.org/vocab/InC/1.0/

repositoryhttps://doi.org/10.17615/z3sw-kr95

https://doi.org/10.1097/inf.0b013e31828be70b

https://europepmc.org/articles/pmc3708263?pdf=render

https://dx.doi.org/10.17615/z3sw-kr95

https://pubmed.ncbi.nlm.nih.gov/23838776

Fields of Study

Antibiotics Pharmacokinetics and EfficacyPharmaceutical studies and practicesAntimicrobial Resistance in Staphylococcus03 medical and health sciences0302 clinical medicine

Keywords

MeropenemImipenem/cilastatinMedicineRetrospective cohort studyAdverse effectImipenemCilastatinCohortPediatricsInternal medicineAntibioticsBiologyMicrobiologyDrug-Related Side Effects and Adverse ReactionsIncidenceCilastatin, Imipenem Drug CombinationInfantSurvival AnalysisAnti-Bacterial AgentsCohort StudiesDrug CombinationsSeizuresIntensive Care, NeonatalHumansThienamycinsRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good health